Taliyan Rajeev, Singh Manjeet, Sharma Pyare Lal, Yadav Harlokesh Narayan, Sidhu Kulwinder Singh
Department of Pharmacology., I.S.F College of Pharmacy, Moga, Punjab - 142 001, India.
J Cardiovasc Dis Res. 2010 Jul;1(3):145-51. doi: 10.4103/0975-3583.70917.
Remote preconditioning is a phenomenon in which brief episodes of ischemia and reperfusion to remote organs protect the target organ against sustained ischemia/reperfusion (I/R)-induced injury. Protective effects of remote aortic preconditioning (RAPC) are well established in the heart, but their mechanisms still remain to be elucidated.
This study has been designed to investigate the possible involvement of α-1-adrenergic receptor (AR) and K(ATP) channels in cardio-protective effect of RAPC in isolated rat heart.
Four episodes of ischemia and reperfusion, each comprising of 5 min occlusion and 5 min reperfusion, were used to produce RAPC. Isolated perfused rat heart was subjected to global ischemia for 30 min followed by reperfusion for 120 min. Coronary effluent was analyzed for LDH and CK-MB release to assess the degree of cardiac injury. Myocardial infarct size was estimated macroscopically using TTC staining.
Phenylephrine (20 μ/kg i.p.), as α-1-AR agonist, was noted to produce RAPC-like cardio-protection. However, administration of glibenclamide concomitantly or prior to phenylephrine abolished cardioprotection. Moreover, prazocin (1 mg/kg. i.p), as α-1-AR antagonist and glibenclamide (1 mg/kg i.p), a K(ATP) channel blocker, abolished the cardioprotective effect of RAPC.
These data provide the evidence that α-1-AR activation involved in cardioprotective effect of RAPC-mediated trough opening of K(ATP) channels.
远程预处理是一种现象,即对远处器官进行短暂的缺血和再灌注可保护靶器官免受持续缺血/再灌注(I/R)诱导的损伤。远程主动脉预处理(RAPC)在心脏中的保护作用已得到充分证实,但其机制仍有待阐明。
本研究旨在探讨α-1肾上腺素能受体(AR)和K(ATP)通道在离体大鼠心脏中RAPC心脏保护作用中的可能作用。
采用4次缺血和再灌注,每次包括5分钟阻断和5分钟再灌注,以产生RAPC。将离体灌注的大鼠心脏进行30分钟的全心缺血,然后再灌注120分钟。分析冠状动脉流出液中乳酸脱氢酶(LDH)和肌酸激酶同工酶(CK-MB)的释放,以评估心脏损伤程度。使用氯化三苯基四氮唑(TTC)染色宏观估计心肌梗死面积。
去氧肾上腺素(20μg/kg腹腔注射)作为α-1-AR激动剂,可产生类似RAPC的心脏保护作用。然而,在去氧肾上腺素之前或同时给予格列本脲可消除心脏保护作用。此外,哌唑嗪(1mg/kg腹腔注射)作为α-1-AR拮抗剂和格列本脲(1mg/kg腹腔注射)作为K(ATP)通道阻滞剂,可消除RAPC的心脏保护作用。
这些数据提供了证据,表明α-1-AR激活参与了RAPC介导的通过打开K(ATP)通道的心脏保护作用。